Private companies are capitalizing on this quest for information. Grail’s Galleri blood test screens for more than 50 ...
PALO ALTO, Calif., Dec. 5, 2025 /PRNewswire/ -- DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, announced ...
For years, routine screening recommendations have been limited to four cancers — breast, cervical, colorectal, and high-risk lung cancer — leaving nearly 70% of annual cancer cases and ...
Costochondritis is not cancer, but its symptoms can resemble those of some types of cancer. It can also develop after certain ...
A new light-based sensor detects cancer markers at near-zero concentrations.
Post-treatment lung health is a longitudinal survivorship issue; nonregenerative parenchymal loss, radiation fibrosis, and systemic-therapy injury justify ongoing symptom reporting, CT/PFT ...
CURRENTLY, ROUTINE CANCER screenings only cover a small slice of cancers. For men in the US, there are guideline-backed screening tests for just two cancers: colorectal and lung cancer (lung ...
But whether patients should be getting the tests—as some already are—is not yet clear. New blood tests can detect cancer recurrence earlier than traditional scans, potentially giving doctors and ...
Small cell lung cancer (SCLC) is a fast-growing cancer that forms in the lung. It's one of two types of lung cancer. The other type is non-small cell lung cancer (NSCLC). SCLC is less common than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results